QI
PBYI icon

QS Investors’s Puma Biotechnology PBYI Stock Holding History

QS Investors’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-11,900
Closed -$121K – 1238
2020
Q3 		$121K Sell
11,900
-46,000
-79% -$468K ﹤0.01% 1112
2020
Q2 		$604K Buy
57,900
+600
+1% +$6.21K 0.01% 854
2020
Q1 		$484K Buy
57,300
+600
+1% +$5.83K 0.01% 849
2019
Q4 		$478K Sell
56,700
-800
-1% -$6.62K ﹤0.01% 951
2019
Q3 		$619K Hold
57,500
– – 0.01% 894
2019
Q2 		$731K Sell
57,500
-1,034
-2% -$23.8K 0.01% 882
2019
Q1 		$2.27M Sell
58,534
-366
-0.6% -$11.2K 0.02% 553
2018
Q4 		$1.2M Hold
58,900
– – 0.02% 720
2018
Q3 		$2.7M Buy
58,900
+57,900
+5,790% +$2.79M 0.03% 521
2018
Q2 		$59K Hold
1,000
– – ﹤0.01% 1490
2018
Q1 		$68K Hold
1,000
– – ﹤0.01% 1442
2017
Q4 		$99K Hold
1,000
– – ﹤0.01% 1388
2017
Q3 		$120K Hold
1,000
– – ﹤0.01% 1382
2017
Q2 		$87K Buy
+1,000
New +$55.9K ﹤0.01% 1411
2016
Q1 		– Sell
-3
Closed -$1K – 2042
2015
Q4 		$1K Buy
+3
New +$235 ﹤0.01% 1754
2015
Q2 		– Sell
-12,753
Closed -$3.01M – 1454
2015
Q1 		$3.01M Sell
12,753
-4,336
-25% -$927K 0.03% 508
2014
Q4 		$3.23M Buy
+17,089
New +$3.79M 0.04% 478

Other funds holding PBYI

DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

QS Investors's PBYI Position: Q4 2020 in Review

QS Investors sold out of Puma Biotechnology (PBYI) in Q4 2020, closing a stake of 11,900 shares — an estimated $121K sold.

QS Investors first reported a position in PBYI in Q4 2014 and held it in 17 quarters. The position peaked at $3.23M in Q4 2014. 123 funds tracked by Wall St. Rank hold PBYI as of Q4 2020.

  • QS Investors reported no remaining Puma Biotechnology position as of Q4 2020 after selling out during the quarter.
  • QS Investors sold 11,900 Puma Biotechnology shares in Q4 2020, an estimated $121K.
  • QS Investors first reported a position in Puma Biotechnology in Q4 2014 and held it in 17 quarters.
  • QS Investors's Puma Biotechnology position peaked at $3.23M in Q4 2014.
  • 123 funds tracked by Wall St. Rank held Puma Biotechnology as of Q4 2020.

Based on QS Investors's 13F filing for Q4 2020, filed 10 Feb 2021.